3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Turcot syndrome
1
Pancreatic Neoplasms
1
Colorectal Neoplasms
1
Interventions
Oxaliplatin
300
Fluorouracil
272
Bevacizumab
237
Gemcitabine
236
Leucovorin
212
Capecitabine
207
pembrolizumab
201
Nivolumab
158
Irinotecan
158
Cisplatin
150
Specimen Handling
144
Magnetic Resonance Spectroscopy
130
130-nm albumin-bound paclitaxel
118
Paclitaxel
109
durvalumab
107
Cetuximab
104
Radiotherapy
99
atezolizumab
94
Drug Therapy
94
Biopsy
93
tislelizumab
81
Albumin-Bound Paclitaxel
81
Taxes
74
Folfox protocol
68
lenvatinib
67
Carboplatin
66
regorafenib
60
Blood Specimen Collection
60
sintilimab
54
Ipilimumab
53
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
IMM-101
×
Gastrointestinal
×
1 year
×
Clear all
NCT06498518
2025-07-11
PRIMUS006
University of Glasgow
Phase 2
Withdrawn
NCT05118724
2025-06-15
ANTONIO
AIO-Studien-gGmbH
Phase 2
Active not recruiting
80 enrolled